Fosun gets Chinese rights to Ardelyx's tenapanor

Gastrointestinal company Ardelyx Inc. (NASDAQ:ARDX) granted Shanghai Fosun Pharmaceutical Group Co. Ltd. (Shanghai:600196; HKSE:2196) exclusive

Read the full 159 word article

User Sign In